4Volpino P,D' Andrea N,Cangemi R. Bronchioloalveolar carcinoma:clinical,radiographic,and pathological findings.Surgical results[J].Journal of Cardiovascular Surgery(Torino),2001,(02):261-267.
5Wislez M,Massiani MA,Milleron B. Clinical characteristics of pneumonic-type adenocarcinoma of the lung[J].Chest,2003,(06):1868-1877.doi:10.1378/chest.123.6.1868.
6邱阳;张也军.肺炎型肺癌3例误诊分析[J]黑龙江医学,2001(04):300.
7Chang CH,Chen KH,Young-Xu Y. The safety and efficacy of gefitinib versus platinum based doublets chemotherapy as the first line treatment for advanced non-small-cell lung cancer patients in East Asia:A meta-analysis[J].Lung Cancer,2008,(02):242-252.doi:10.1016/j.lungcan.2008.03.001.
8Andre L. Bronchioloalveolar carcinoma and ninimally invasive adenocarcinona[J].Surgical Pathology,2010,(01):1-26.
9Wislez M,Antoine M,Baudrin L. Non-mucinnus and mucinous subtypes of aden ocarcinoma with hronchioloalveolar carcinoma features differ hy biomarker expression and in theresponse to gefitinib[J].Lung Cancer,2010,(02):185-191.doi:10.1016/j.lungcan.2009.05.021.
10T ravis MD. The new IASLC/AT S/ERS international multidisciplinary lung adenocarcinoma classification[J].JOURNAL OF THORACIC ONCOLOGY,2009,(09):86-89.